• 1
    World Health Organization. Make every mother and child count. World Health Report, 2005. WHO: Geneva, 2005.
  • 2
    Royal College of Obstetricians and Gynaecologists (RCOG). Why mothers die 2000–2002: the sixth report of confidential enquiries into maternal deaths in the United Kingdom, LewisG (ed.). RCOG Press: London, 2004.
  • 3
    ACOG Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin: diagnosis and management of pre-eclampsia and eclampsia: number 33, January 2002. Obstet Gynecol 2002; 99: 159167.
  • 4
    National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Clinical Excellence. Antenatal care: Routine care for the healthy pregnant woman. Clinical Guideline: October 2003.
  • 5
    Yu CK, Smith GCS, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of pre-eclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005; 193: 429436.
  • 6
    Campbell S, Diaz-Recasens J, Griffin DR, Cohen-Overbeek TE, Pearce JM, Willson K, Teague MJ. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983; 26: 675677.
  • 7
    Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, Purwar M, Hofmeyr J, Nguyen TN, Campodonico L, Landoulsi S, Carroli G, Lindheimer M; World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006; 194: 639649.
  • 8
    Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006; 354: 17961806.
  • 9
    Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Lancet 2006; 367: 11451154.
  • 10
    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 17911798.
  • 11
    Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet 1998; 351: 343346.
  • 12
    Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 4567.
  • 13
    Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 583586.
  • 14
    Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892898.
  • 15
    Gardosi J, Francis A. Software program for the calculation of customized birth weight percentiles. Version 6.2, 2000–2007; Published on
  • 16
    Royston P, Thompson SG. Model-based screening by risk with application to Down's syndrome. Stats in Med 1992; 11: 257268.
  • 17
    Detti L, Johnson SC, Diamond MP, Puscheck EE. First- trimester Doppler investigation of the uterine circulation. Am J Obstet Gynecol 2006; 195: 12101218.
  • 18
    Resnik R, Killam AP, Battaglia FC, Makowski EL, Meschia G. The stimulation of uterine blood flow by various estrogens. Endocrinology 1974; 94: 11921196.
  • 19
    Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991; 266: 237241.
  • 20
    Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565572.
  • 21
    von Dadelszen P, Magee LA, Roberts JM. Subclassification of pre-eclampsia. Hypertens Pregnancy 2003; 22: 143148.
  • 22
    Witlin GA, Saade GR, Mattar FM, Sibai BM. Predictors of neonatal outcome in women with severe pre-eclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 1999; 1: S19.
  • 23
    Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 11731177.
  • 24
    Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113: 580589.
  • 25
    Khaw A, Kametas NA, Turan O, Bamfo JEAK, Nicolaides KH. Maternal cardiac function and uterine artery Doppler at 11–14 weeks in the prediction of pre-eclampsia in nulliparous women. BJOG 2007; (in press).
  • 26
    Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006; 27: 1317.
  • 27
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672683.